Quest Diagnostics (NYSE:DGX) Price Target Increased to $150.00 by Analysts at UBS Group
Quest Diagnostics (NYSE:DGX – Get Rating) had its target price increased by stock analysts at UBS Group from $139.00 to $150.00 in a note issued to investors on Sunday, The Fly reports. UBS Group’s price objective would suggest a potential upside of 9.34% from the company’s previous close. Several other brokerages also recently issued reports […]